Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03671226 · ClinicalTrials.gov registry record · NA
Preference of Room Setting and Waiting Time in Patients With Advanced, Locally Advanced, or Metastatic Cancer and Their Caregivers Who Are Seen in the Outpatient Supportive/Palliative Care Center
A NA study of Caregiver and Advanced Malignant Neoplasm, sponsored by M.D. Anderson Cancer Center.
- Active
- Registry status
- NA
- Development phase
- 406
- Enrollment target
- 1
- Study location
NCT03671226: Active NA study of Caregiver and Advanced Malignant Neoplasm, sponsored by M.D. Anderson Cancer Center.
NCT03671226 is a NA study of Caregiver and Advanced Malignant Neoplasm that is active but no longer recruiting, run by M.D. Anderson Cancer Center. The registered enrollment target is 406 participants, below the 1,236-participant average among 20 other Caregiver trials with a reported enrollment target (67% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03671226, a NA study of Caregiver and Advanced Malignant Neoplasm, is active but no longer recruiting, sponsored by M.D. Anderson Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 406 participants
- Enrollment target
- 1
- Study location
Study Summary
This trial studies the preference of room setting and waiting time in patients with cancer that has spread to nearby tissue or lymph nodes or other places in the body and their caregivers who are seen in the outpatient supportive/palliative care center. Room setting preferences of patients and caregivers may help to understand their opinion regarding direct rooming system in the outpatient supportive/palliative care center.
Primary Outcome
Two sample t-test or Wilcoxon rank sum test, whichever more appropriate, will be used to compare continuous variables of interest between the preference of exam room over waiting area. Chi-squared test or Fisher's exact test, whichever appropriate, will be used to test for associations between each of categorical variables and preference of exam room over waiting area. Univariate/multicovariate logistic regression analysis will be used to explore the demographics and clinical factors associated
Conditions Studied
Interventions
- OTHER Questionnaire Administration
Study Locations (1)
Texas
- M D Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 406 participants |
| Start Date | 2018-09-28 |
| Est. Completion | 2027-12-31 |
| Phase | NA |
What the registry record for NCT03671226 still lists
NCT03671226 is an interventional study that assigns participants to a tested intervention. The registered 406 participants enrollment target is mid-sized for trials with a published cap, below the 1,236-participant average among 20 other Caregiver trials with a reported enrollment target (67% lower).
The record links to 4 conditions, with Caregiver appearing as the primary indexed condition, and to 1 intervention - of which Questionnaire Administration is the first listed.
NCT03671226 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT03671226 about?
NCT03671226 is a clinical study titled "Preference of Room Setting and Waiting Time in Patients With Advanced, Locally Advanced, or Metastatic Cancer and Their Caregivers Who Are Seen in the Outpatient Supportive/Palliative Care Center". This trial studies the preference of room setting and waiting time in patients with cancer that has spread to nearby tissue or lymph nodes or other places in the body and their caregivers who are seen in the outpatient supportive/palliative care center. Room setting preferences of patients and careg...
What is the current status of trial NCT03671226?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 406 participants. The study started on 2018-09-28. Estimated completion is 2027-12-31.
What conditions does trial NCT03671226 study?
This clinical trial studies the following conditions: Caregiver, Advanced Malignant Neoplasm, Metastatic Malignant Neoplasm, Locally Advanced Malignant Neoplasm.
What interventions are being tested in trial NCT03671226?
The interventions under investigation include: Questionnaire Administration (OTHER).
Who is sponsoring clinical trial NCT03671226?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03671226 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Caregiver
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03671226's enrollment target sits among peer trials
406 4th of 20 higher than 17 of 20 other Caregiver trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Caregiver trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Behavioral Health Program for Short-Stay Nursing Facility Residents & Care Partners
RECRUITING · NA
-
Support for Bereaved Cancer Caregivers
RECRUITING · NA
-
The REACH Intervention for Caregivers of Veterans and Service Members With TBI
RECRUITING · NA
-
mHealth for Early Psychosis Caregivers in Statewide Program Outreach
RECRUITING · NA
-
FearLess in NeuroOncology
RECRUITING · NA
-
Multimedia Self-Management Intervention for Lung Cancer Surgery Family Caregivers and Patients
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06223360 · 406 participants · Phase 2
A Trial to Evaluate the Safety and Efficacy of Benfotiamine in Patients With Early Alzheimer's Disease (BenfoTeam)
- NCT06411769 · 406 participants · NA
Evidence-based Intervention to Improve Walking Engagement in El Paso, Texas
- NCT06585787 · 406 participants · Phase 3
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
- NCT06735534 · 407 participants · NA
Repeat Ablation of Persistent Atrial Fibrillation, Including Mitral Isthmus Catheter Ablation, With the FARAPULSE Pulsed Field Ablation System
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI